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Background.This study investigated an association between systemic absolute neutrophil count (ANC) and albuminuria in elderly
Chinese people. Methods. A cross-sectional study was conducted on 2265 participants attending a routine medical examination
in Minhang District as part of a Platform of Chronic Disease program. Their drug history, waist circumference, height, blood
pressure, fasting blood glucose, ANC, and urine albumin levels were recorded. This study conformed to the requirements of the
STROBE statement. Results. Of the 2265 subjects, 1254 (55.4%) were diabetic and 641 (28.3%) had albuminuria. The mean ANC
of patients with diabetes comorbid with macroalbuminuria was significantly higher than that of both the nondiabetic patients and
patients with diabetes with lower levels of albuminuria; the latter 2 groups had statistically similar ANC. ANC significantly and
positively correlated with levels of urine albumin. Based on multivariate analysis, with each 109/L increase in ANC, the increase in
rates of macroalbuminuria was significant but not in rates of albuminuria positivity. Based on areas under the receiver operating
characteristic curve, ANC was the strongest factor predicting macroalbuminuria. Conclusions. Elevated ANC was associated
with macroalbuminuria in diabetes, indicating that neutrophil-mediated inflammation may be involved in the exacerbation of
albuminuria.
1. Introduction
Albuminuria (i.e., urinary albumin, or UA) is defined as an
abnormally high amount of albumin in the urine and is a
strong sign of early renal damage [1–4]. In type 2 diabetes
and nondiabetic subjects, albuminuria is also associated
with early- and long-term cardiovascular mortality [5, 6].
Elevated UA reflects a general state of widespread endothelial
dysfunction and vascular damage [7–10].
Inflammation and endothelial dysfunction may be key
mechanisms in the development of albuminuria [11–13].
However, evidence of an association between markers of
inflammation and albuminuria is limited and controversial.
In diabetic subjects with albuminuria, no differences in
C-reactive protein levels (a marker of inflammation) were
observed compared with healthy controls [14]. Yet in another
study, serum levels of sialic acid, another marker of inflam-
mation, correlated with increasing albumin excretion [15].
Absolute neutrophil count (ANC) is also a sensitive
marker of inflammation, and the test for it is simple and inex-
pensive. Recently, clinical studies have shown a link between
neutrophils and the development of diabetic retinopathy [16–
18]. Although albuminuria is an accepted sign of early renal
injury, it is not known whether the ANC is related.
We hypothesized an association between ANC and UA
levels. Like the world’s human population in general, China’s
is aging and we chose to study the elderly. Here, the UA
creatinine ratio (UACR) was used as a measure of albumin
excretion. Since overnight UACR correlates well with UA
excretion [9], this study specifically investigated an associa-
tion between systemic ANC and UACR in an elderly Chinese
population.
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2. Subjects and Methods
2.1. Study Participants. This community-based, cross-sec-
tional study focused on the clinical risk factors of albumin-
uria.We performed the study with outpatients of our hospital
in Shanghai, from March to August of 2010. All community-
dwelling participants aged ≥60 years, including those
residing in private residences and personal care homes, were
recruited to a Platform of Chronic Disease (PCD) prevention
program for a routine medical checkup. Participants who
could not come to the prevention center were interviewed
in their place of residence by trained personnel. Those who
refused to join the study were not included in this analysis.
The participants provided informed consent.
All questionnaires and procedures were approved by the
Institutional Review Board in our hospital for research with
human subjects. The identification of diabetes was based on
the diagnostic criteria recommended by the American Dia-
betes Association in 1997. Potential subjects included those
with a history of past diabetes or who had newly received
a diagnosis by oral glucose tolerance test [19].
In total, 3053 subjects aged between 60 and 91 years
(median age: 70 y) were considered for the study. The fol-
lowing subjects were excluded: 28 subjects presenting with
painful urination, fever, cough, or skin damage; 5 subjects
who were incontinent and not capable of caring for them-
selves; and 12 subjects with white blood cell (WBC) counts
≥10 × 109/L or serum creatinine (SCr) ≥141 𝜇mol/L. Ulti-
mately, 3003 subjects were selected for this study. Further 738
subjects had missing UA data, because they did not collect
morning urine samples.
Therefore, 2265 subjects were included in the final analy-
sis.
2.2. Hematological Analysis. Blood samples were collected
at 8:15 a.m. after a 12-hour fast. The subjects underwent a
glucose tolerance test with a 75 g oral glucose overload. Only
water was permitted during the test period and no physical
exercise was taken. The blood samples were collected by
EDTA tube before and at 2 h after the tolerance test. After
centrifugation, samples were stored at −80∘C for subsequent
analysis. Plasma biochemical parameters were measured in
duplicate by standard enzymatic methods. Glucose, choles-
terol, triglycerides, SCr, and alanine aminotransferase (ALT)
levels were measured using a Dimension Vista analyzer
(Siemens AG). WBC, ANC, and ANC/WBC ratio values
were measured using an automated 5-category hematology
analyzer (Japanese Sysmex XS1000i).
2.3. UA Assessment. Participants were asked to collect a ran-
dom morning spot urine sample in a clean, lidded container.
All urine samples were assessed centrally in a single reference
laboratory at Fifth Hospital, Shanghai, China. Samples were
centrifuged at 1500×g for 10min and then stored at −80∘C
prior to analysis. Further analysis was performedwith a Beck-
man Coulter Array 360 chemistry analyzer. Test results were
considered positive for albuminuria (UA+) at an albumin-to-
creatinine ratio (ACR) >0mg/g; otherwise the results were
accepted as negative (UA−; ACR = 0mg/g). Microalbumin-
uria, or a moderate increase in UA, was identified as an ACR
from 30 to 299mg/g. Macroalbuminuria was defined as ACR
≥300mg/g.
2.4. Physical Inspection. Blood pressure was measured twice
at about 8:00 a.m., with the subject seated andwith an interval
of 5min between measurements. Blood pressure measure-
ments were taken on the right arm, which was relaxed and
supported by a table, at an angle of 45∘ from the trunk
(sphygmomanometer, Yutu, Shanghai, China). Hypertension
was defined as systolic blood pressure (SBP) ≥140mmHg or
diastolic blood pressure (DBP) ≥90mmHg.
The following measurements were recorded for all sub-
jects: height, weight, waist circumference (horizontal position
of the anterior superior iliac crest and twelfth rib edge
midpoint), and hip measurement (measuring horizontally
from the front of the pubic symphysis to the most convex
point behind the gluteus maximus) by experienced nurses in
the PCD program. Body mass index (BMI) was calculated as
weight/height2 (kg/m2).
2.5. Statistical Analysis. Mann-Whitney 𝑈 tests and chi-
squared tests were used for analysis of continuous variables
and categorical variables, respectively. The ANC levels of
the following subgroups of patients were calculated and
compared by analysis of variance: nondiabetic; diabetic
without albuminuria; diabetic with low-level albuminuria
(0 < UA < 30mg/g); diabetic with microalbuminuria (UA
30–299mg/g); and diabetic with macroalbuminuria (UA ≥
300mg/g).
The least significant difference was used for intergroup
comparisons. All subjects were categorized into 5 groups
according to the quintile of ANC levels (I–V). Multivariate
logistic regression analysis was used to investigate an inde-
pendent association between ANC and UA. Differences were
considered significant at 𝑃 ≤ 0.05.
Receiver operating characteristic (ROC) curves were
plotted for factors predicting macroalbuminuria. Areas
under the ROC (AUC) curve ≥0.5 were considered statisti-
cally significant (SPSS software version 17.0; SPSS, Chicago,
IL, USA).
3. Results
Thedata analysis included 2265 participants aged between 60
and 91 years (median: 70 y)with amale-to-female ratio of 56.8
to 43.1 (Table 1). Compared with the 1011 participants who
were free of diabetes, the 1254 participants with diabetes were
older, with a higher prevalence of hypertension and increased
SBP, ANC, WBC, ANC/WBC, and fasting blood glucose
(FBG).The 641 participants testing positive for UACR (UA+)
were older, with higher BMI and waist-to-hip ratio, SBP, DBP,
SCr, ANC, WBC, and ANC/WBC compared with the 1624
persons testing negative for UACR (UA−).
As described in Subjects and Methods, all subjects were
classified as follows: nondiabetic; diabetic without albumin-
uria; diabetic with low-level albuminuria; diabetic with
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Table 1: Demographic and clinical data of patients∗.
Diabetes Albuminuria
Diabetic Nondiabetic 𝑃 UA+ UA− 𝑃
Subjects, 𝑛 1254 1011 641 1624
Mean age, y 71 (65–76) 70 (65–75) 0.021 70 (65–75) 70 (65–75) 0.0028
Gender, male/female 721/932 566/784 NS 266/375 717/906 NS
BMI, kg/m2 23.7 (21.4–26.0) 23.9 (21.6–26.3) NS 24.0 (21.8–26.5) 23.6 (21.2–25.8) 0.0012
Waist-hip ratio 0.88 (0.84–0.91) 0.88 (0.84–0.91) NS 0.88 (0.84–0.91) 0.87 (0.84–0.90) 0.0002
SBP, mmHg 132 (127–147) 130 (125–142) 0.0066 133 (128–148) 130 (124–140) <0.0001
DBP, mmHg 80 (75–83) 80 (76–83) NS 80 (76–84) 80 (74–81) 0.0019
Hypertension 774 (1254) 568 (1011) 0.0045 384 (641) 924 (1624) NS
ACE inhibitor 73 (1254) 39 (1011) 0.0007 31 (641) 60 (1624) NS
ARB 197 (1254) 128 (1011) 0.0218 91 (641) 222 (1624) NS
Total cholesterol, mmol/L 5.8 (5.0–6.5) 5.8 (5.1–6.5) NS 5.8 (5.0–6.5) 5.8 (5.1–6.5) NS
Triglycerides, mmol/L 1.8 (1.3–2.4) 1.8 (1.3–2.4) NS 1.8 (1.3–2.4) 1.7 (1.2–2.3) NS
FBG, mmol/L 5.7 (5.3–7.4) 5.8 (5.5–6.2) <0.0001 5.9 (5.4–6.6) 5.8 (5.4–6.4) NS
Two-hour glucose, mmol/L 8.4 (6.8–12.9) 8.5 (7.9–9.3) 0.0032 8.5 (7.2–10.7) 8.4 (7.1–10.3) NS
SCr, 𝜇mol/L 69 (58–90) 70 (60–81) NS 70 (59–2) 68.5 (60–78) 0.0038
ALT, U/L 21 (16–27) 21 (17–28) NS 21 (16–28) 21 (16–27) NS
WBC, 109/L 6.0 (5.1–7.0) 5.9 (5.1–6.8) 0.0138 6.0 (5.1–7.0) 5.8 (5.0–6.8) 0.0131
ANC, 109/L 3.5 (2.8–4.3) 3.3 (2.8–4.3) 0.0001 3.4 (2.8–4.2) 3.3 (2.7–4.0) <0.0001
ANC/WBC, % 57.6 (50.8–63.9) 56.3 (49.8–62.3) 0.0007 58.0 (51.9–64.0) 56.2 (50.8–62.3) 0.0006
ACR, mg/g 6.4 (0–20.8) 3.2 (0–12.6) 0.0002 9.2 (27–19.2) 0 <0.0001
∗Data are presented as median and 25th–75th percentile, unless otherwise noted.
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; NS, not significant.
Table 2: ANC quintiles in relation to the risk of macroalbuminuria
and positive UA, OR (95% CI).
ANC, 103/𝜇L Macroalbuminuria∗ UA+∗
I ≤2.6 Referent level Referent level
II 2.6 to 3.2 0.996 (0.691–1.435) 1.271 (0.963–1.677)
III 3.2 to 3.7 1.458 (1.012–2.099) 1.333 (0.993–1.791)
IV 3.7 to 4.4 1.351 (0.932–1.958) 1.352 (1.000–1.827)
V >4.4 2.311 (1.608–3.321) 1.573 (1.148–2.154)
∗
𝑃 for trend ≤0.0001 and 0.0653 for macroalbuminuria and UA+, respec-
tively, adjusted for age, BMI, gender, SBP, DBP, and SCr.
microalbuminuria; or diabetic with macroalbuminuria (Fig-
ure 1). ANC levels andANC/WBC increasedwith the severity
of UA (𝑃 < 0.0001). Patients with macroalbuminuria had
significantly higher ANC and ANC/WBC counts than did
the patients in the other 4 groups (𝑃 < 0.001). There was no
statistical difference between the other 4 groups.
Regarding the results of the multivariate logistic regres-
sion analyses, after adjustments for age, BMI, gender, SBP,
DBP, and SCr, the odds ratios (ORs) indicated that ANC
levels significantly correlated with risk of macroalbuminuria
(𝑃 < 0.0001). Compared with quintile I of ANC, quintile V of
ANChad the highestORvalue (2.311, 95% confidence interval
[CI]: 1.608–3.321; Table 2).
ROC curves were plotted to evaluate the diagnostic value
of age, BMI, waist-to-hip ratio, gender, SBP, DBP, ALT,
SCr, total cholesterol, triglycerides, FBG, 2-hour glucose,
and ANC for macroalbuminuria. ANC was the strongest
predictive factor for macroalbuminuria (AUC = 0.6001)
followed closely by FBG (AUC = 0.5876) and SBP (AUC =
0.5767; Table 3).
To investigate interactions among ANC, FBG, SBP, and
SCr, they were grouped in separate analyses. ANC × FBG ×
SBP (Model 2; variables are multiplied) and ANC × FBG ×
SBP × SCr (Model 3) indicated 1.67% and 3.12% increase,
respectively, in the predictive value for macroalbuminuria,
compared with Model 1 (ANC × FBG), but these increases
were not statistically significant (𝑃 = 0.5188 and 0.5338).
Thus ANC and FBG were the most meaningful diagnostic
indices for macroalbuminuria.
4. Discussion
This study investigated an association between systemic
ANC and albuminuria in elderly Chinese people. We found
that ANCs significantly increased in diabetes with macroal-
buminuria, and ANC was the strongest factor predicting
macroalbuminuria. These results indicate that neutrophil-
mediated inflammation may be involved in the exacerbation
of albuminuria.
To the best of our knowledge, this is the first report
describing an association between UA and ANC levels in
a population-based study. It is perplexing that the systemic
neutrophil count, a very simple and inexpensive laboratory
parameter, has not been reported previously in association
with UA, although data from a study of 30 793 people
4 International Journal of Endocrinology
Table 3: AUCs for predicting macroalbuminuria.
AUC (95% CI) Fold change∗ 𝑃
ANC, 103/𝜇L 0.6001 (0.5689–0.6313) — —
FBG, mmol/L 0.5876 (0.5561–0.6191) — —
SCr, 𝜇mol/L 0.5545 (0.5225–0.5869) — —
SBP, mmHg 0.5767 (0.5457–0.6077) — —
Model 1 ANC × FBG 0.6179 (0.5872–0.6486) — —
Model 2 ANC × FBG × SBP 0.6282 (0.6068–0.6676) 1.67 0.5188
Model 3 ANC × FBG × SBP × SCr 0.6372 (0.5978–0.6586) 3.12 0.5338





















































































































































Figure 1: ANC and ANC/WBC ratios of groups stratified by UA severity. The ANC value and ANC/WBC ratio of the group with diabetes
andmacroalbuminuria were much higher than those of the other 4 groups. A: compared with nondiabetes group, 𝑃 < 0.05. B: compared with
diabetes without UA, 𝑃 < 0.05. C: compared with diabetes with low-level UA, 𝑃 < 0.05. D: compared with diabetes with macroalbuminuria,
𝑃 < 0.05.
conducted in Korea showed an association betweenANC and
diabetic retinopathy, after adjusting for the effects of blood
pressure, blood glucose, and SCr [16].
In our present study, patients with albuminuria or those
with diabetes had higher ANC levels. To study further the
association between diabetes, UA, and ANC, subjects were
stratified into a nondiabetic group and 4 groups with diabetes
at different levels of severity of albuminuria. We found that
patients with diabetes with macroalbuminuria had a notably
highermeanANC than did the other 4 groups.There were no
statistical differences among the other 4 groups. In addition,
ANC was an independent indicator of macroalbuminuria,
but it was not an independent indicator of UA+. Thus, ANC
might have an important role in accelerating the progression
of albuminuria but not the formation of urinary protein.
Although establishing a causal mechanism for the associ-
ation betweenANCand albuminuriawas beyond the scope of
this study, the underlying linkmay concern vascular damage.
In clinical and laboratory studies, elevated neutrophil counts
were found associated with increased levels of tumor necrosis
factor- (TNF-) 𝛼, cytokine-induced neutrophil chemotactic
factor 2 alpha/beta (CINC-2𝛼/𝛽), interleukin- (IL-) 1𝛽, IL-
6, and C-reactive protein, as well as excessive production of
superoxide and reactive oxygen species [20–23]. Based on
the results of the present study and past investigations, we
hypothesize that the systemic neutrophil count reflects the
local number of neutrophils in renal vessels [24, 25]. Under
the influence of proinflammatory cytokines, neutrophils in
renal vessels are activated and their adhesion is intensified
[26]. These responses cause abnormal leukocyte-endothelial
interactions and ultimately vascular damage [27].
In the present study, compared with the other 4 quintile
ANC groups, the highest level of the ANC group had the
highest OR for the risk of macroalbuminuria and not quin-
tiles II or III. This shows that the higher the ANC level, the
more likely the presence of macroalbuminuria, reflecting an
overtly inflammatory status in patients withmacroalbuminu-
ria [24, 27]. The exact mechanism is not clear, but whether
changes in the function or shape of neutrophils are involved
warrants further research.
There are several limitations to our study. First, the study
design was cross-sectional and therefore we were not able to
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confirm a causal link between ANC and macroalbuminuria.
Second, the inclusion of participants attending a routine
health checkup in one community represents a potential
source of selection bias, which should be considered when
interpreting the results. Third, information regarding other
traditional risk factors for albuminuria, such as heavy exer-
cise [28], could not be obtained and analyzed in this study.
Despite these limitations, our study involved many clinical
and laboratory parameters in a large number of subjects
and showed a new clinical risk factor for albuminuria in
individuals, 60 years of age and older.
5. Conclusion
This clinical study revealed an association between elevated
systemic neutrophil counts and macroalbuminuria. High
levels of UA may indicate an overt inflammatory state. The
potential effect of neutrophil-mediated inflammation in the
progression of macroalbuminuria warrants further research.
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